Cited by 436Cardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesGout, Hyperuricemia, Uric Acid

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

Cappola, Thomas P., Kass, David A., Nelson, Gregory S., Berger, Ronald D., Rosas, Gisele O., Kobeissi, Zoulficar A., Marbán, Eduardo, Hare, Joshua M.·2001·Circulation

DOI 10.1161/hc4501.098928

Open this paper in CoChat — free account

Abstract

Background Dilated cardiomyopathy is characterized by an imbalance between left ventricular performance and myocardial energy consumption. Experimental models suggest that oxidative stress resulting from increased xanthine oxidase (XO) activity contributes to this imbalance. Accordingly, we hypothesized that XO inhibition with intracoronary allopurinol improves left ventricular efficiency in patients with idiopathic dilated cardiomyopathy. Methods and Results Patients (n=9; ejection fraction, 29±3%) were instrumented to assess myocardial oxygen consumption (MV̇ o 2 ), peak rate of rise of left ventricular pressure (dP/dt max ), stroke work (SW), and efficiency (dP/dt max /MV̇ o 2 and SW/MV̇ o 2 ) at baseline and after sequential infusions of intracoronary allopurinol (0.5, 1.0, and 1.5 mg/min, each for 15 minutes). Allopurinol caused a significant decrease in MV̇ o 2 (peak effect, −16±5%; P <0.01; n=9) with no parallel decrease in dP/dt max or SW and no change in ventricular load. The net result was a substantial improvement in myocardial efficiency (peak effects: dP/dt max /MV̇ o 2 , 22±9%, n=9; SW/MV̇ o 2 , 40±17%, n=6; both P <0.05). These effects were apparent despite concomitant treatment with standard heart failure therapy, including ACE inhibitors and β-blockers. XO and its parent enzyme xanthine dehydrogenase were more abundant in failing explanted human myocardium on immunoblot. Conclusions These findings indicate that XO activity may contribute to abnormal energy metabolism in human cardiomyopathy. By reversing the energetic inefficiency of the failing heart, pharmacological XO inhibition represents a potential novel therapeutic strategy for the treatment of human heart failure.

Integrity signals

Registry

Crossref · 10.1161/hc4501.098928

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
Doucette, J. W., Corl, P. D., Payne, H. M., Flynn, A. E., Goto, M., Nassí, M., & Segal, J. (1992) · Circulation · doi:10.1161/01.cir.85.5.1899 · Cited by 1,017
Activation of the Cardiac Calcium Release Channel (Ryanodine Receptor) by Poly-S-Nitrosylation
Xu, L., Eu, J. P., Meissner, G., & Stamler, J. S. (1998) · Science · doi:10.1126/science.279.5348.234 · Cited by 991
Effective arterial elastance as index of arterial vascular load in humans.
Kelly, R. P., Ting, C.-T., Yang, T. M., Liu, C. P., Maughan, W. L., Chang, M.-S., & Kass, D. A. (1992) · Circulation · doi:10.1161/01.cir.86.2.513 · Cited by 832
Self-citation
Ventricular energetics
Suga, H. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.247 · Cited by 744
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
Cohn, J. N., Goldstein, S., Greenberg, B., Lorell, B. H., Bourge, R. C., Jaski, B. E., Gottlieb, S. O., McGrew, F. A., DeMets, D. L., & White, B. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392503 · Cited by 612
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
Keith, M. E., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 560
Elevated Levels of 8-iso-Prostaglandin F2αin Pericardial Fluid of Patients With Heart Failure
Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998) · Circulation · doi:10.1161/01.cir.97.16.1536 · Cited by 458
Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.
Campbell, D. L., Stamler, J. S., & Strauss, H. C. (1996) · The Journal of general physiology · doi:10.1085/jgp.108.4.277 · Cited by 441

Show all 31 references

Research works printed but not linked: 9

10.1161/circ.93.5.932 · DOI
10.1161/circ.97.16.1536 · DOI
10.1161/res.83.4.423 · DOI
10.1161/res.85.5.437 · DOI
10.1161/circ.103.5.750 · DOI
10.1161/circ.92.8.2198 · DOI
10.1161/circ.94.10.2497 · DOI
10.1161/circ.97.4.363 · DOI
10.1161/circ.103.6.826 · DOI

Sorted by citations

Oxygen, oxidative stress, hypoxia, and heart failure
Giordano, F. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24408 · Cited by 1,515
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D., Feig, D. I., Kivlighn, S. D., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodríguez‐Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,354
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,277
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
Berry, C. E., & Hare, J. M. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055913 · Cited by 925
Self-citation
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans
Marrocco, I., Fabio Altieri, F., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6501046 · Cited by 907
Treating Oxidative Stress in Heart Failure: Past, Present and Future
van der Pol, A., van Gilst, W. H., Voors, A. A., & van der Meer, P. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1320 · Cited by 838
Structure and function of xanthine oxidoreductase: where are we now?
Harrison, R. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00956-5 · Cited by 807
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 784
Self-citation
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
The role of oxidants and free radicals in reperfusion injury
Zweier, J. L., & Talukder, M. F. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.025 · Cited by 743
The Right Ventricle Under Pressure
Bogaard, H. J., Abe, K., Noordegraaf, A. V., & Voelkel, N. F. (2009) · CHEST Journal · doi:10.1378/chest.08-0492 · Cited by 692
Uric acid and inflammatory markers
Ruggiero, C., Cherubini, A., Blè, A., Bós, Â. J. G., Maggio, M. G., Dixit, V. D., Lauretani, F., Bandinelli, S., Senin, U., & Ferrucci, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi879 · Cited by 601
Uric Acid and Survival in Chronic Heart Failure: Validation and Application in Metabolic, Functional, and Hemodynamic Staging
Anker, S. D., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C. H., Cicoira, M., Shamim, W., Kemp, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065637.10517.a0 · Cited by 593
Increased myocardial NADPH oxidase activity in human heart failure
Heymes, C., Bendall, J. K., Ratajczak, P., Cave, A. C., Samuel, J., Hasenfuss, G. P., & Shah, A. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00471-6 · Cited by 582
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
Casella, G., Carr, E., Davies, J. I., Belch, J. J. F., & Struthers, A. D. (2006) · Circulation · doi:10.1161/circulationaha.106.651117 · Cited by 574
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure
Doehner, W., Schoene, N., Rauchhaus, M., Leyva‐Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G. C., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure
Landmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., Kohler, C., Harrison, D. G., Hornig, B., & Drexler, H. (2002) · Circulation · doi:10.1161/01.cir.0000041431.57222.af · Cited by 525
The role of uric acid in the pathogenesis of human cardiovascular disease
Kanbay, M., Segal, M. S., Afşar, B., Kang, D., Rodríguez‐Iturbe, B., & Johnson, R. J. (2013) · Heart · doi:10.1136/heartjnl-2012-302535 · Cited by 458
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease
Kanellis, J., & Kang, D. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.09.007 · Cited by 444
Relationship Between Serum Uric Acid Concentration and Insulin Resistance and Metabolic Syndrome
Yoo, T. W., Sung, K., Shin, H. S., Kim, B. J., Kim, B. S., Kang, J. H., Lee, M. H., Park, J. R., Kim, H. Y., Rhee, E., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.928 · Cited by 412
Impact of Oxypurinol in Patients With Symptomatic Heart Failure
Hare, J. M., Mangal, B., Brown, J., Fisher, C., Freudenberger, R., Colucci, W. S., Mann, D. L., Liu, P., Givertz, M. M., & Schwarz, R. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.068 · Cited by 392
Self-citation
The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
Raedschelders, K., Ansley, D. M., & Chen, D. D. Y. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.004 · Cited by 393
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
D’Oria, R., Schipani, R., Leonardini, A., Natalicchio, A., Perrini, S., Cignarelli, A., Laviola, L., & Giorgino, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5732956 · Cited by 399
Oxidative Stress as a Mediator of Cardiovascular Disease
Elahi, M. M., Kong, Y. X. G., & Matata, B. M. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9441 · Cited by 364
NO/redox disequilibrium in the failing heart and cardiovascular system
Hare, J. M., & Stamler, J. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524459 · Cited by 361
Self-citation
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
Baker, J. F., Krishnan, E., Chen, L., & Schumacher, H. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.043 · Cited by 354
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
Noman, A., Ang, D. S. C., Ogston, S. A., Lang, C. C., & Struthers, A. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60391-1 · Cited by 348
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Murdoch, C. E., Zhang, M., Cave, A. C., & Shah, A. M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.016 · Cited by 344
Inflammation as a Therapeutic Target in Heart Failure? A Scientific Statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Heymans, S. R. B., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J., Tervaert, J. W. C., Drexler, H., Filippatos, G. S., Felix, S. B., Gullestad, L. L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 325
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Givertz, M. M., Anstrom, K. J., Redfield, M. M., Deswal, A., Haddad, H., Butler, J., Tang, W. H. W., Dunlap, M. E., LeWinter, M. M., Mann, D. L., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014536 · Cited by 296
Self-citation
Molecular targets and regulators of cardiac hypertrophy
Rohini, A., Agrawal, N. K., Koyani, C. N., & Singh, R. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.012 · Cited by 304
Uric acid and oxidative stress: Relative impact on cardiovascular risk
Strazzullo, P., & Puig, J. G. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.011 · Cited by 281
Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal?
Soltani, Z., Rasheed, K., Kapusta, D. R., & Reisin, E. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0344-5 · Cited by 271
Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme
Battelli, M. G., Bolognesi, A., & Polito, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.022 · Cited by 256
“enzyme activity by allopurinol administration resulted in a significant improvement in myocardial efficiency [151].”
Background
Redox signaling in cardiovascular health and disease
Madamanchi, N. R., & Runge, M. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.001 · Cited by 227
Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling
Khan, S. A., Lee, K., Minhas, K. M., González, D. R., Raju, S. V. Y., Tejani, A. D., Li, D., Berkowitz, D. E., & Hare, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404136101 · Cited by 227
Self-citation
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
Casella, G. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4265 · Cited by 214
Allopurinol Attenuates Left Ventricular Remodeling and Dysfunction After Experimental Myocardial Infarction
Engberding, N., Spiekermann, S., Schaefer, A., Heineke, A., Wiencke, A., Müller, M. F., Fuchs, M., Hilfiker‐Kleiner, D., Hornig, B., Drexler, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000144303.24894.1c · Cited by 209
Critical Role of the NAD(P)H Oxidase Subunit p47 phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction
Doerries, C., Grote, K., Hilfiker-Kleiner, D., Luchtefeld, M., Schaefer, A., Holland, S. M., Sorrentino, S., Manes, C., Schieffer, B., Drexler, H., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000261657.76299.ff · Cited by 206
Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure
Ungvari, Z. I., Gupte, S. A., Recchia, F. A., Bátkai, S., & Pacher, P. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161054368607 · Cited by 205
Crosstalk Between Calcium and Redox Signaling: From Molecular Mechanisms to Health Implications
Hidalgo, C., & Donoso, P. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1886 · Cited by 199
Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart
Saavedra, W. F., Paolocci, N., John, M. E. S., Skaf, M. W., Stewart, G. C., Xie, J.-S., Harrison, R. W., Zeichner, J., Mudrick, D. W., Marbán, E., et al. (2002) · Circulation Research · doi:10.1161/hh0302.104531 · Cited by 196
Self-citation
Journal of Pharmaceutical and Biomedical Sciences
(2016) · Journal of Pharmaceutical and Biomedical Sciences · doi:10.20936/jpbms · Cited by 193
Role of endothelial dysfunction in heart failure
Zuchi, C., Tritto, I., Carluccio, E., Mattei, C., Cattadori, G., & Ambrosio, G. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09881-3 · Cited by 208
Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure
Oginö, K., Kato, M., Furuse, Y., Kinugasa, Y., Ishida, K., Osaki, S., Kinugawa, T., Igawa, O., Hisatome, I., Shigemasa, C., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.868604 · Cited by 191
Mechanisms and Use of Calcium-Sensitizing Agents in the Failing Heart
Kass, D. A., & Solaro, R. J. (2006) · Circulation · doi:10.1161/circulationaha.105.542407 · Cited by 189
Self-citation
Antioxidants in Cardiovascular Therapy: Panacea or False Hope?
Goszcz, K., Deakin, S. J., Duthie, G. G., Stewart, D., Leslie, S. J., & Megson, I. L. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00029 · Cited by 188
Antioxidant activity of carvedilol in cardiovascular disease
Dandona, P., Ghanim, H., & Brooks, D. P. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280127948 · Cited by 181
Nitric oxide and excitation–contraction coupling
Hare, J. M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00143-3 · Cited by 179
Self-citation
Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy
Minhas, K. M., Saraiva, R. M., Schuleri, K. H., Lehrke, S., Zheng, M., SALIARIS, A. P., Berry, C. E., Vandegaer, K., Li, D., & Hare, J. M. (2005) · Circulation Research · doi:10.1161/01.res.0000200181.59551.71 · Cited by 170
Self-citation
Nitroso–Redox Interactions in the Cardiovascular System
Zimmet, J. M., & Hare, J. M. (2006) · Circulation · doi:10.1161/circulationaha.105.605519 · Cited by 163
Self-citation
Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?
Dawson, J., & Walters, J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02785.x · Cited by 167
Oxidative Stress and Hyperuricaemia: Pathophysiology, Clinical Relevance, and Therapeutic Implications in Chronic Heart Failure
Bergamini, C., Cicoira, M., Rossi, A., & Vassanelli, C. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp042 · Cited by 166
Hyperuricemia and Associated Diseases
Becker, M. A., & Jolly, M. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.02.005 · Cited by 165
Uric Acid Predicts Clinical Outcomes in Heart Failure
Hare, J. M., & Johnson, R. J. (2003) · Circulation · doi:10.1161/01.cir.0000066420.36123.35 · Cited by 165
Self-citation
Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta‐Analysis
Higgins, P., Dawson, J., Lees, K. R., McArthur, K., Quinn, T. J., & Walters, M. R. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00277.x · Cited by 164
Cardiovascular Drugs and Serum Uric Acid
Reyes, A. J. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000015855.02485.e3 · Cited by 163
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart
Gupte, S. A., Levine, R. J., Gupte, R. S., Young, M. E., Lionetti, V., Labinskyy, V., Floyd, B. C., Ojaimi, C., Bellomo, M., Wolin, M. S., et al. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.05.003 · Cited by 162
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease Possible role for left ventricular remodelling
Kameda, K. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.022 · Cited by 161
Nitroso–Redox Balance in the Cardiovascular System
Hare, J. M. (2004) · New England Journal of Medicine · doi:10.1056/nejme048269 · Cited by 162
Self-citation
Redox Regulation of Sodium and Calcium Handling
Wagner, S., Rokita, A. G., Anderson, M. E., & Maier, L. S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4818 · Cited by 157
Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats
Ribes, A. M., Hernandez, C., Kunduzova, O., Bompart, G., Cambon, C., Parini, A., & Francès, B. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00700.2002 · Cited by 153
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
McKinsey, T. A., & Kass, D. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2193 · Cited by 152
Self-citation
Molecular Mechanisms in Heart Failure
Hilfiker-Kleiner, D., Landmesser, U., & Drexler, H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.007 · Cited by 151
Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP
Johnson, T. A., Jinnah, H. A., & Kamatani, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00098 · Cited by 151
Uric Acid as a Predictor of All-Cause Mortality in Heart Failure: A Meta-Analysis
Tamariz, L. J., Harzand, A., Palacio, A., Verma, S., Jones, J. L., & Hare, J. M. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00200.x · Cited by 146
Self-citation
Gout, Allopurinol Use, and Heart Failure Outcomes
Thanassoulis, G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.198 · Cited by 147
Increased Oxidative Stress and Cardiomyocyte Myofibrillar Degeneration in Patients With Chronic Isolated Mitral Regurgitation and Ejection Fraction >60%
Ahmed, M. I., Gladden, J. D., Litovsky, S. H., Lloyd, S. G., Gupta, H., Inusah, S., Denney, T. S., Powell, P. C., McGiffin, D. C., & Dell’Italia, L. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.074 · Cited by 141
Myocardial energetics in heart failure
Nickel, A. G., Löffler, J., & Maack, C. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0358-9 · Cited by 148
Short-Term Treatment With Ranolazine Improves Mechanical Efficiency in Dogs With Chronic Heart Failure
Chandler, M. P., Stanley, W. C., Morita, H., Suzuki, G., Roth, B. A., Blackburn, B. K., Wolff, A. A., & Sabbah, H. N. (2002) · Circulation Research · doi:10.1161/01.res.0000031151.21145.59 · Cited by 139
NADPH oxidases and cardiac remodelling
Nabeebaccus, A., Zhang, M., & Shah, A. M. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9186-2 · Cited by 138
NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa
Usui, S., Oveson, B. C., Lee, S. Y., Jo, Y., Yoshida, T., Miki, A., Miki, K., Iwase, T., Lu, L., & Campochiaro, P. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06195.x · Cited by 138
ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress
Wang, X., Zhang, G., Dasgupta, S., Niewold, E. L., Li, C., Li, Q., Luo, X., Tan, L., Ferdous, A., Lorenzi, P. L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321050 · Cited by 137
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Casas, A. I., Dao, V. T.-V., Daiber, A., Maghzal, G. J., Di Lisa, F., Kaludercic, N., Leach, S., Cuadrado, A., Jaquet, V., Seredenina, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6433 · Cited by 136
Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death
Bottomley, P. A., Panjrath, G. S., Lai, S., Hirsch, G. A., Wu, K. C., Najjar, S. S., Steinberg, A. M., Gerstenblith, G., & Weiss, R. G. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007328 · Cited by 140
The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease
Kikuchi, K., Tancharoen, S., Takeshige, N., Yoshitomi, M., Morioka, M., Murai, Y., & Tanaka, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713909 · Cited by 134
Association between serum uric acid and atrial fibrillation: A systematic review and meta-analysis
Tamariz, L. J., Hernandez, F., Bush, A. L., Palacio, A., & Hare, J. M. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.003 · Cited by 131
Self-citation
Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
Rajendra, N. S., Ireland, S., Casella, G., Belch, J. J. F., Lang, C. C., & Struthers, A. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.052 · Cited by 131
Cardiac cachexia
Anker, S. D., Steinborn, W., & Strassburg, S. (2004) · Annals of Medicine · doi:10.1080/07853890410017467 · Cited by 129
Modulation of cardiac ryanodine receptor activity by ROS and RNS
Donoso, P. (2010) · Frontiers in bioscience · doi:10.2741/3705 · Cited by 129
Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation
Kang, L.-L., Zhang, D., Ma, C., Zhang, J., Jia, K., Liu, J.-H., Wang, R., & Kong, L. (2016) · Scientific Reports · doi:10.1038/srep27460 · Cited by 128
Remodeling of Calcium Handling in Human Heart Failure
Lou, Q., Janardhan, A. H., & Efimov, I. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_52 · Cited by 123
The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata Study
Cingolani, H. E., Plastino, J. A. M., Escudero, E. M., Mangal, B., Brown, J., & Pérez, N. G. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.05.005 · Cited by 117
Hyperuricemia predicts adverse outcomes in patients with heart failure
Hamaguchi, S., Furumoto, T., Tsuchihashi‐Makaya, M., Goto, K., Goto, D., Yokota, T., Kinugawa, S., Yokoshiki, H., Takeshita, A., & Tsutsui, H. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.05.002 · Cited by 117
Association of Serum Uric Acid With Incident Atrial Fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study)
Tamariz, L. J., Agarwal, S. K., Soliman, E. Z., Chamberlain, A. M., Prineas, R. J., Folsom, A. R., Ambrose, M., & Alonso, Á. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.043 · Cited by 115
NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology
Cave, A. C., Grieve, D., Johar, S., Zhang, M., & Shah, A. M. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1772 · Cited by 113
Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy
Stull, L. B., Leppo, M. K., Szweda, L. I., Gao, W. D., & Marbán, E. (2004) · Circulation Research · doi:10.1161/01.res.0000148635.73331.c5 · Cited by 110
Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes
Dey, S., Sidor, A., & O'Rourke, B. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.726968 · Cited by 115
Angiotensin II and Oxidative Stress in the Failing Heart
Zablocki, D., & Sadoshima, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4588 · Cited by 110
Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options
Doehner, W., & Landmesser, U. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.007 · Cited by 110
Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes
Sag, C. M., Wagner, S., & Maier, L. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.035 · Cited by 112
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure
Gavin, A. D., & Struthers, A. D. (2005) · Heart · doi:10.1136/hrt.2004.040477 · Cited by 106
Allopurinol Acutely Increases Adenosine Triphospate Energy Delivery in Failing Human Hearts
Hirsch, G. A., Bottomley, P. A., Gerstenblith, G., & Weiss, R. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.895 · Cited by 103
Role of Oxidative Stress in Cardiac Remodelling after Myocardial Infarction
Grieve, D., Byrne, J., Cave, A. C., & Shah, A. M. (2004) · Heart Lung and Circulation · doi:10.1016/j.hlc.2004.02.008 · Cited by 106
Allopurinol as a therapeutic option in cardiovascular disease
Okafor, O., Farrington, K., & Gorog, D. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.12.004 · Cited by 102
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure
Pacher, P., Liaudet, L., Mabley, J. G., Komjáti, K., & Szabó, C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02062-4 · Cited by 97
Posttranslational modifications of cardiac ryanodine receptors: Ca2+ signaling and EC-coupling
Niggli, E., Ullrich, N. D., Gutierrez, D. A., Kyrychenko, S., Polaková, E., & Shirokova, N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.016 · Cited by 99
Oxidative Stress in Heart Failure: What Are We Missing?
Sawyer, D. B. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182249fcd · Cited by 93

Authors: Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M.
Affiliations: Johns Hopkins University (US)
From the Department of Medicine, Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Md.
ORCID: Cappola, Thomas P.
Kass, David A.
Berger, Ronald D.
Hare, Joshua M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-11-13
Volume: 104
Issue: 20
Pages: 2407-2411
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/hc4501.098928
OpenAlex: W2129194977
Cited by: 436
References: 31
Citations by year: 2026: 3 · 2025: 9 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 12 · 2018: 12 · 2017: 17 · 2016: 12 · 2015: 17 · 2014: 21 · 2013: 27 · 2012: 25
FWCI: 11.93
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: Johns Hopkins University
National Institutes of Health
National Heart, Lung, and Blood Institute (K08HL003238, K08-HL-03238, R01 HL65455, R01HL065455)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords: allopurinol, idiopathic dilated cardiomyopathy, xanthine oxidase inhibition, myocardial energy metabolism, myocardial oxygen consumption, stroke work, heart failure treatment, xanthine dehydrogenase, oxidative stress
MeSH terms: Allopurinol, Cardiomyopathy, Dilated, Enzyme Inhibitors, Female, Hemodynamics, Humans, Male, Middle Aged, Myocardial Contraction, Myocardium, Oxygen Consumption, Xanthine Oxidase, Oxidative Stress, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks